Literature DB >> 19514047

Highly unstable sequence interruptions of the CTG repeat in the myotonic dystrophy gene.

Zuzana Musova1, Radim Mazanec, Anna Krepelova, Edvard Ehler, Jiri Vales, Radka Jaklova, Tomas Prochazka, Petr Koukal, Tatana Marikova, Josef Kraus, Marketa Havlovicova, Zdenek Sedlacek.   

Abstract

Myotonic dystrophy type 1 is caused by the expansion of a CTG repeat in the 3' UTR of the DMPK gene. A length exceeding 50 CTG triplets is pathogenic. Intermediate alleles with 35-49 triplets are not disease-causing but show instability in intergenerational transmissions. We report on the identification of multiple patients with different patterns of CCG and CTC interruptions in the DMPK CTG repeat tract that display unique intergenerational instability. In patients bearing interrupted expanded alleles, the location of the interruptions changed dramatically between generations and the repeats tended to contract. The phenotype for these patients corresponded to the classical form of the disease, but in some cases without muscular dystrophy and possibly with a later onset than expected. Symptomatic patients bearing interrupted intermediate length repeat tracts were also identified, although the role of the interruptions in their phenotype remains unclear. The identification of interruptions in the DMPK repeat has important consequences for molecular genetic testing where they can lead to false negative conclusions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19514047     DOI: 10.1002/ajmg.a.32987

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  61 in total

1.  Allele length of the DMPK CTG repeat is a predictor of progressive myotonic dystrophy type 1 phenotypes.

Authors:  Gayle Overend; Cécilia Légaré; Jean Mathieu; Luigi Bouchard; Cynthia Gagnon; Darren G Monckton
Journal:  Hum Mol Genet       Date:  2019-07-01       Impact factor: 6.150

2.  Expanded CTG repeat demarcates a boundary for abnormal CpG methylation in myotonic dystrophy patient tissues.

Authors:  Arturo López Castel; Masayuki Nakamori; Stephanie Tomé; David Chitayat; Geneviève Gourdon; Charles A Thornton; Christopher E Pearson
Journal:  Hum Mol Genet       Date:  2010-11-01       Impact factor: 6.150

3.  Replacement of the myotonic dystrophy type 1 CTG repeat with 'non-CTG repeat' insertions in specific tissues.

Authors:  Michelle M Axford; Arturo López-Castel; Masayuki Nakamori; Charles A Thornton; Christopher E Pearson
Journal:  J Med Genet       Date:  2011-05-27       Impact factor: 6.318

Review 4.  Myotonic dystrophy mouse models: towards rational therapy development.

Authors:  Mário Gomes-Pereira; Thomas A Cooper; Geneviève Gourdon
Journal:  Trends Mol Med       Date:  2011-07-02       Impact factor: 11.951

5.  Comprehensive genotyping of the C9orf72 hexanucleotide repeat region in 2095 ALS samples from the NINDS collection using a two-mode, long-read PCR assay.

Authors:  Eran Bram; Kamyab Javanmardi; Kimberly Nicholson; Kristen Culp; Julie R Thibert; Jon Kemppainen; Vivian Le; Annette Schlageter; Andrew Hadd; Gary J Latham
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2018-11-15       Impact factor: 4.092

Review 6.  The muscular dystrophies: distinct pathogenic mechanisms invite novel therapeutic approaches.

Authors:  Zarife Sahenk; Jerry R Mendell
Journal:  Curr Rheumatol Rep       Date:  2011-06       Impact factor: 4.592

Review 7.  Myotonic dystrophy: disease repeat range, penetrance, age of onset, and relationship between repeat size and phenotypes.

Authors:  Kevin Yum; Eric T Wang; Auinash Kalsotra
Journal:  Curr Opin Genet Dev       Date:  2017-02-14       Impact factor: 5.578

8.  Molecular genetic and clinical characterization of myotonic dystrophy type 1 patients carrying variant repeats within DMPK expansions.

Authors:  Jovan Pešović; S Perić; M Brkušanin; G Brajušković; V Rakočević-Stojanović; Dušanka Savić-Pavićević
Journal:  Neurogenetics       Date:  2017-09-23       Impact factor: 2.660

9.  Modelling and inference reveal nonlinear length-dependent suppression of somatic instability for small disease associated alleles in myotonic dystrophy type 1 and Huntington disease.

Authors:  Catherine F Higham; Darren G Monckton
Journal:  J R Soc Interface       Date:  2013-09-18       Impact factor: 4.118

10.  Scaled-down genetic analysis of myotonic dystrophy type 1 and type 2.

Authors:  Masayuki Nakamori; Krzysztof Sobczak; Richard T Moxley; Charles A Thornton
Journal:  Neuromuscul Disord       Date:  2009-08-26       Impact factor: 4.296

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.